Press Releases May 1, 2026 04:31 PM

NATURAL GAS SERVICES GROUP, INC. REPORTS FIRST QUARTER 2026 FINANCIAL AND OPERATING RESULTS

Natural Gas Services Group to report Q1 2026 financial results and host conference call

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
NGS

Natural Gas Services Group, Inc., a provider of natural gas and electric compression equipment and services to the energy industry, will release its first quarter 2026 financial results after market close on May 11, 2026, and hold a conference call on May 12, 2026. The company operates primarily in the oil and natural gas production sectors and serves U.S. energy markets.

NATURAL GAS SERVICES GROUP, INC. REPORTS FIRST QUARTER 2026 FINANCIAL AND OPERATING RESULTS
NGS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • NGS will announce Q1 2026 financial results after market close on May 11, 2026.
  • A conference call to discuss results will be held on May 12, 2026, at 8:30 a.m. Eastern Time.
  • NGS specializes in renting, designing, and maintaining compressors and related services for oil and gas production and plant facilities in major U.S. basins.

Southlake, Tx, May 01, 2026 (GLOBE NEWSWIRE) -- Natural Gas Services Group, Inc. (NYSE: NGS), a leading provider of natural gas compression equipment, technology and services to the energy industry, announced today that it will host a conference call to review its first quarter financial results on Tuesday, May 12, 2026, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).


The Company’s first quarter for 2026 financial and operating results for the period ending March 31, 2026, will be released after market close on May 11, 2026, and will be available on the Company’s website at www.ngsgi.com.


To participate in the conference call, please access the Investor Relations section of the Company’s website at www.ngsgi.com or dial (800) 550-9745 and enter conference ID 167298 at least five minutes prior to the scheduled start time. Please note that use of the dial-in number is required to participate in the question-and-answer portion of the call. A replay of the conference call will be available on the Company’s website following the conclusion of the call.


About Natural Gas Services Group, Inc.
Natural Gas Services Group is a leading provider of natural gas and electric compression equipment, technology, and services to the energy industry. The Company rents, designs, and maintains electric and natural gas compressors for oil and natural gas production and plant facilities. NGS is headquartered in Southlake, Texas, with an assembly facility located in Tulsa, Oklahoma, and service facilities located in major oil and natural gas producing basins in the U.S. Additional information can be found at www.ngsgi.com.

For Additional Information

Investor Relations
Natural Gas Services Group, Inc.
(432) 262-2700
ir@ngsgi.com
www.ngsgi.com


Risks

  • Financial results may reflect challenges in the volatile energy sector impacting revenue and profitability.
  • Dependence on oil and natural gas production activity levels could affect demand for compression equipment and services.
  • Broader energy market conditions, including commodity prices and regulatory changes, could influence company performance.

More from Press Releases

Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control Jun 14, 2026 Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026 Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026